Endovastec(SH:688016) Zheng Quan Zhi Xing·2025-09-02 16:15Core Viewpoint - The company, Shanghai MicroPort MedBot (Group) Co., Ltd., is progressing with its second phase of share repurchase, aiming to enhance employee stock ownership and incentivize staff through the repurchased shares [1][2]. Summary by Sections 1. Basic Information on Share Repurchase - The second phase of the share repurchase plan was first disclosed on October 30, 2024, with an implementation period from October 28, 2024, to October 27, 2025 [1]. - The expected repurchase amount ranges from 100 million to 200 million RMB [1]. - The repurchased shares will be used for employee stock ownership plans or equity incentives [1]. - As of the latest update, a total of 1,228,743 shares have been repurchased, accounting for 1.00% of the total share capital [1]. - The total amount spent on repurchases so far is approximately 129.07 million RMB, with a price range of 84.26 RMB to 120.00 RMB per share [1][2]. 2. Progress of Share Repurchase - As of August 31, 2025, the company has repurchased 1,228,743 shares, with the highest transaction price being 120.00 RMB and the lowest at 84.26 RMB [2]. - The total transaction amount for the repurchased shares is approximately 15.81 million RMB for the month, excluding transaction fees [2]. - The repurchase activities comply with relevant laws and regulations [2]. 3. Other Matters - The company will adhere to the regulations regarding share repurchase and will disclose information on the progress of the repurchase in a timely manner [3].